About Retatrutide Script

What this site is

Retatrutide Script is an independent editorial project that publishes summaries of the peer-reviewed research literature on retatrutide. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The domain name contains the word "script" — that is an SEO convention for search terms people use when looking up a compound. It does not mean this site prescribes, fills, or dispenses anything. There are no scripts here, and there is nothing to fill.

What we read and why

Retatrutide is one of the most-watched investigational drugs in the obesity and metabolic disease research space. Phase 2 data produced weight-loss numbers that exceeded what prior drug classes had achieved. Phase 3 is running. A head-to-head comparison trial is ongoing. These are important findings in an important area — and most of what appears online about retatrutide is either vendor copy or community speculation, not the actual trial record.

This site reads the actual trial record. Phase 1b pharmacokinetics. Phase 2 obesity, diabetes, and MASLD data. Cryo-EM structural findings. Systematic reviews. We cite every quantitative claim to its study. We report what was measured, not what someone hopes it will do.

We also report community signals from research-use settings — clearly labeled as anecdotal, clearly separated from the trial evidence. Both matter to someone trying to understand the full picture.

Editorial standards

Quantitative claims are cited. Sources are PubMed-indexed journal articles, ClinicalTrials.gov trial records, and peer-reviewed reviews. We do not report claims we cannot cite. We do not speculate about Phase 3 outcomes beyond what is in the peer-reviewed record.

Retatrutide is investigational. We say so clearly and consistently. It is not FDA-approved, not commercially available, and not a drug you can be prescribed as of mid-2026. We do not frame it as a treatment or a solution — we frame it as a compound that has produced specific measured results in specific populations under controlled trial conditions.

The Retatrutide references page lists every study cited on this site with full bibliographic details and links.

Contact and corrections

Found an error in a citation or a factual claim? Contact us. We correct mistakes. If a trial has published that we have not yet covered, we want to know. This site is a reading desk, not an archive of fixed text — it updates when the literature does.